Based on a 3% compound annual growth rate (CAGR), treatments for prurigo nodularis are predicted to be valued US$ 693.3 million in 2023 and US$ 930.9 million by 2033.The market for prigo nodularis therapy is anticipated to rise significantly over the next several years due to a number of important factors, including higher R&D costs, …